Filters

Phase
    Intervention Type
      Status
        Location:
        LocationClose
        Distance
          Term Search
          You can select from the dropdown list OR enter your own terms to refine the search.

          Last Updated: 10/31/2025

          Need to find the closest trial?
          Sort By Distance
          Save trials for later
          Sign Up
          Not sure about your diagnosis?
          Check Your Symptoms
          1 clinical trial found

            Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

            Targeting Residual Activity By Precision, Biomarker-Guided Combination Therapies of Multiple Sclerosis (TRAP-MS)

            Who is this study for: Patients with Multiple Sclerosis
            Enrollment Status: Recruiting
            Publish Date: July 10, 2025
            Intervention Type: Drug
            Study Drugs: Pioglitazone, Clemastine Fumarate, Hydroxychloroquine, Dantrolene
            Study Phase: Phase 1/Phase 2

            Background: In people with multiple sclerosis (MS), brain and cerebrospinal fluid (CSF) biomarkers indicate inflammation or disease. Researchers want to see if 4 drugs given alone or combined affect MS biomarkers. They want to see if a change in biomarker levels can predict which drugs a person with MS might respond to.

            Showing 1-1 of 1

            Last Updated: 10/31/2025